Bismuth Subsalicylate “Relieves Travelers’ Diarrhea” Claim Proposed by FDA
This article was originally published in The Tan Sheet
Executive Summary
Relief of travelers' diarrhea would be included as an indication for bismuth subsalicylate products in the OTC antidiarrheal drug final monograph under a proposed rule published in the 1April 17 Federal Register